Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06246409 · ClinicalTrials.gov registry record · NA
Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy
A NA study of Cancer, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 650
- Enrollment target
- 1
- Study location
NCT06246409: Recruiting NA study of Cancer, sponsored by University of Florida.
NCT06246409 is a NA study of Cancer that is actively recruiting participants, run by University of Florida. The registered enrollment target is 650 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06246409, a NA study of Cancer, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 650 participants
- Enrollment target
- 1
- Study location
Study Summary
Daily patient participation is critical to the successful, life-saving delivery of radiotherapy. There is very little in the literature describing the best way to prepare patients to give optimal participation. This study aims to look at an already-prepared conversion of patient instruction materials and measure whether the improvement in clarity and specificity produces the desired changes in patient decision-making and emotional comfort.
Primary Outcome
Determine the number of unintentional missed days of treatment during a course of radiotherapy
Conditions Studied
Interventions
- BEHAVIORAL Modernized patient instructions
- BEHAVIORAL Existing patient instructions
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2024-12-24 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06246409 shows while recruiting
NCT06246409 is an interventional study that assigns participants to a tested intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Modernized patient instructions is the first listed.
NCT06246409 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06246409 about?
NCT06246409 is a clinical study titled "Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy". Daily patient participation is critical to the successful, life-saving delivery of radiotherapy. There is very little in the literature describing the best way to prepare patients to give optimal participation. This study aims to look at an already-prepared conversion of patient instruction material...
What is the current status of trial NCT06246409?
This trial is currently recruiting. It is a NA study. The enrollment target is 650 participants. The study started on 2024-12-24. Estimated completion is 2026-12.
What conditions does trial NCT06246409 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT06246409?
The interventions under investigation include: Modernized patient instructions (BEHAVIORAL), Existing patient instructions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06246409?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06246409 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06246409's enrollment target sits among peer trials
650 107th of 615 higher than 508 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI